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Abstract
Background: Intestinal schistosomiasis was not considered endemic in Lake Malawi until November 2017 when
populations of Biomphalaria pfeifferi were first reported; in May 2018, emergence of intestinal schistosomiasis was
confirmed. This emergence was in spite of ongoing control of urogenital schistosomiasis by preventive
chemotherapy. Our current study sought to ascertain whether intestinal schistosomiasis is transitioning from
emergence to outbreak, to judge if stepped-up control interventions are needed.
Methods: During late-May 2019, three cross-sectional surveys of primary school children for schistosomiasis were
conducted using a combination of rapid diagnostic tests, parasitological examinations and applied morbidity-
markers; 1) schistosomiasis dynamics were assessed at Samama (n = 80) and Mchoka (n = 80) schools, where
Schistosoma mansoni was first reported, 2) occurrence of S. mansoni was investigated at two non-sampled schools,
Mangochi Orphan Education and Training (MOET) (n = 60) and Koche (n = 60) schools, where B. pfeifferi was nearby,
and 3) rapid mapping of schistosomiasis, and B. pfeifferi, conducted across a further 8 shoreline schools (n = 240).
After data collection, univariate analyses and Chi-square testing were performed, followed by binary logistic
regression using generalized linear models, to investigate epidemiological associations.
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Results: In total, 520 children from 12 lakeshore primary schools were examined, mean prevalence of S. mansoni by
‘positive’ urine circulating cathodic antigen (CCA)-dipsticks was 31.5% (95% confidence interval [CI]: 27.5–35.5). Upon
comparisons of infection prevalence in May 2018, significant increases at Samama (relative risk [RR] = 1.7, 95% CI:
1.4–2.2) and Mchoka (RR = 2.7, 95% CI: 1.7–4.3) schools were observed. Intestinal schistosomiasis was confirmed at
MOET (18.3%) and Koche (35.0%) schools, and in all rapid mapping schools, ranging from 10.0 to 56.7%. Several
populations of B. pfeifferi were confirmed, with two new eastern shoreline locations noted. Mean prevalence of
urogenital schistosomiasis was 24.0% (95% CI: 20.3–27.7).
Conclusions: We notify that intestinal schistosomiasis, once considered non-endemic in Lake Malawi, is now
transitioning from emergence to outbreak. Once control interventions can resume after coronavirus disease 2019
(COVID-19) suspensions, we recommend stepped-up preventive chemotherapy, with increased community-access
to treatments, alongside renewed efforts in appropriate environmental control.
Keywords: Emergence, Schistosoma mansoni, Urine CCA-dipstick, Faecal occult blood, Co-infection, Morbidity,
COVID-19
Background
Lake Malawi is the world’s fourth largest freshwater lake,
an important aquatic hotspot of global biodiversity but
with urogenital schistosomiasis being endemic along many
parts of its shoreline [1]. In Mangochi District, Malawi,
the prevalence of Schistosoma haematobium infection in
school children warrants preventive chemotherapy. This is
achieved by annual mass drug administration (MDA) of
praziquantel [2] as provided by the Malawi National Schis-
tosomiasis and Soil-Transmitted Helminthiasis Control
Programme (https://www.health.gov.mw/index.php/schis-
tosomiasis-sth-control-programme). MDA is typically
guided upon country-wide mapping information which is
usually developed from inspection of five schools per dis-
trict [3]. By contrast, intestinal schistosomiasis, caused by
Schistosoma mansoni, is not considered endemic within
the lake, as being congruent with the absence of Biompha-
laria pfeifferi, an obligatory intermediate snail host and
keystone snail species for parasite transmission [1, 4, 5].
This appraisal was revised in May 2018 as, since No-
vember 2017 B. pfeifferi has been repeatedly encountered
in the lake, alongside emergence of intestinal schisto-
somiasis documented in three local primary schools [6].
Prevalence of infection by ‘trace/positive’ urine circulat-
ing cathodic antigen (CCA)-dipsticks was 34.3% (95%
CI: 27.9–41.3), with ova-patent S. mansoni in stool noted
at Samama and Mchoka schools [6]. Even with ongoing
annual MDA for urogenital schistosomiasis control, the
dynamics of intestinal schistosomiasis need further scru-
tiny here, for this disease could transition from emer-
gence to outbreak.
Transitions from emergence to outbreak are often
driven by expansions in the distributions of intermediate
snail hosts which, like elsewhere in Africa, can instigate,
for example, new transmission foci [7]. Even though an
outbreak terminology is rather vaguely defined, common
with the epidemiology of other water-borne diseases [8],
it is more so for schistosomiasis as its transmission
dynamics also involve unsafe water contact, with per-
cutaneous (and oral) entry and infection routes. How-
ever, the use of outbreak vernacular can be appropriate,
foremost, to spur commensurate public health actions,
for example in stepped-up surveillance for the inter-
mediate hosts or with intensified control interventions.
This was evidenced in Senegal for intestinal schistosom-
iasis [9] and more recently in Corsica for urogenital
schistosomiasis [10] which were each urged by the use
of outbreak terminologies.
To seek an appropriate public health response here on
the shoreline of Lake Malawi, our investigation had three
linked objectives: 1) to resample Samama and Mchoka
schools, ascertaining the dynamics of schistosomiasis in-
fection and morbidity after annual MDA, 2) to confirm
intestinal schistosomiasis, also noting faecal occult blood
(FOB), at two previously non-sampled schools, Mango-
chi Orphan Education and Training (MOET) and Koche
schools, where in 2018 B. pfeifferi was found nearby and
3) to conduct a wider rapid mapping survey for schisto-
somiasis at eight further schools (St Augustine II,
Ndembo, Chikomwe, Chipeleka, Sungusya, St Martins,
Makumba and Mtengeza) to judge if an outbreak of in-
testinal schistosomiasis was occurring.
Methods
Study design and sample size determination for each
objective
A cross-sectional study design was used to achieve the
three study objectives, see STROBE checklist within sup-
plemental materials. Based on previous epidemiological
information [6], a sample size calculation with single
population proportion formula (http://www.raosoft.com/
samplesize.html) showed that a total sample size of 520
was sufficient to estimate overall prevalence of intestinal
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and urogenital schistosomiasis with < ± 5% precision
and 95% confidence.
Based on prevalence data provided by the authors of
the May 2018 study [6], a Fisher’s exact test was used to
show that sampling of 80 children from each of Samama
and Mchoka schools in June 2019 was sufficient to de-
tect a 25-percentage-point rise in prevalence of each
Schistosoma species at each school (α < 0.05, β < 0.20)
(objective 1). To ensure detection of S. mansoni if
present at MOET and Koche schools (objective 2), 60
children were sampled from each. For objective 3, ac-
cording to World Health Organisation (WHO) recom-
mendations for rapid mapping, 30 children per school
were sampled per school [11]. Random sampling was
used at each school following stratification by age and
gender. A study flow diagram is included (see Fig. 1).
Study area
At each school, global position system (GPS) coordinates
were taken using an Oregon 650 receiver (Garmin, Olathe,
Kansas, USA). The GPS locations for each school in decimal
degrees are as follows: Samama (− 14.417465o, 35.217580o),
Mchoka (− 14.439481o, 35.220644o), MOET (− 14.320776o,
35.131558 o), Koche (− 14.330917o, 35.146186o), St August-
ine II (− 14.473926o, 35.279613o), Ndembo (− 14.456385o,
35.273794o), Chikomwe (− 14.422136o, 35.265088o), Chipe-
leka (− 14.385387o, 35.292935o), Sungusya (− 14.386472o,
35.311398o), St Martins (− 14.351401o, 35.294435o),
Makumba (− 14.319806o, 35.286104o) and Mtengeza (−
14.288932o, 35.264073o). A location map of the 12 schools is
shown (see Fig. 2).
Inclusion/exclusion criteria, diagnostics and praziquantel
treatment of participants
The surveys took place during late May/June 2019; after
obtaining written informed parental consent for each
child, a total of 520 children, aged 6–15, of balanced gen-
der, were enrolled. Children not attending school and
acutely unwell children were excluded. Participants could
withdraw consent at any point. On the appointed day of
survey, each school child provided a mid-morning urine
sample and when requested, a stool sample, alongside
undertaking a brief interview by questionnaire document-
ing place of birth, recent travel, water-contact habits and
praziquantel treatment history. If found infected, upon
ova patent infection or ‘trace/positive’ urine CCA-dipstick
test, each child was provided with praziquantel (IDA
Foundation, Amsterdam, The Netherlands) at 40mg/kg.
For detection of intestinal schistosomiasis, two drops
of urine were applied to a CCA-dipstick (Rapid Medical
Diagnostics, Pretoria, South Africa). Results were scored
visually against a reference colour photograph as ‘nega-
tive’, ‘trace’ or ‘positive’ and cross-checked [12]. To aug-
ment urine CCA-dipsticks, on-site inspection of
Fig. 1 A study flow-chart of the objectives, sample size and
methods used during this investigation
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collected stool was performed with parasitological
methods; at Mchoka, Samama, MOET and Koche
schools, all children were asked to provide a stool sam-
ple with a total of 265 specimens obtained (see Table 1).
Following our rapid mapping protocol at 8 remaining
schools, stool was only requested from urine CCA-
dipstick ‘positive’ children, obtaining 70 specimens (see
Table 1).
To visualize helminth ova in stool, individual speci-
mens were filtered across a 212 μm metal mesh then ap-
plied to produce duplicate thick (41.7 mg) Kato-Katz
[11] smears as examined for lateral spine S. mansoni ova
by microscopy (× 100). Intensity of S. mansoni infection
as eggs per gram (epg) was classified as: light (1–99 epg),
medium (100–399 epg) and heavy (≥ 400 epg) according
to WHO guidelines [11]. To assess putative pathology
associated with intestinal schistosomiasis [5], stools were
screened for FOB using ALLTEST® cassettes (Access
Diagnostic Tests UK Ltd., Aylsham, UK).
For detection of urogenital schistosomiasis, 10ml of
well-mixed urine was filtered by syringe across a circular
nylon mesh of 1.5 cm diameter, with 20 μm pore size
(Plastok® [Meshes and Filtration] Ltd., Birkenhead, UK).
The mesh was stained with Lugol’s iodine, then inspected
by microscopy (× 100) to count terminal spined S. haema-
tobium ova. Infection intensity was classified as light (< 50
ova per 10ml) or heavy (≥ 50 ova per 10ml) according to
WHO guidelines [11]. Putative pathology associated with
Fig. 2 Schematic map showing the prevalence of intestinal schistosomiasis in June 2019, by sampled school, and by urine CCA-dipsticksFreshwater
sites inspected for Biomphalaria pfeifferi over the November 2017–December 2019 period are also shown [Note that schools denoted with a flag
represent locations where ova-patent Schistosoma mansoni infection was observed, and the schools associated with objectives 1–3. The black arrow
labelled ‘A’ denotes the bay area as shown in Fig. 4 where the shoreline has changed during the 2005–2016 period, most likely due to lowering lake
levels and local sedimentation, where numerous B. pfeifferi (n≥ 10) have been consistently found]. +ve: positive; −ve: negative
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urogenital schistosomiasis was assessed by Siemens Multi-
stix® 10 SG reagent strips (Medisave UK Ltd., Weymouth,
UK) for microhematuria [5].
Malacological surveillance
During May/June 2019, all known locations where B.
pfeifferi was found were re-surveyed, alongside several
new locations as visited on the eastern shoreline of the
lake, based upon convenience sampling from in-field ob-
servations of human water contact. At each site, two col-
lectors searched, for 20 min, for B. pfeifferi by hand and
with metal sieves. GPS coordinates, altitude and location
photographs were taken with an Oregon 650 receiver
(Garmin, Olathe, Kansas, USA). Water temperature (°C),
pH and conductivity (μS) were recorded with a HI-
98129 Pocket EC/TDS and pH Tester (Hanna Instru-
ments Ltd., Leighton Buzzard, Bedfordshire, UK). Col-
lected snails were kept for a week and screened daily for
shedding S. mansoni cercariae by exposure to sunlight
under a dissecting microscope (× 20).
Data analyses
Demographic, questionnaire and diagnostic data were
tabulated with statistical analysis carried out using IBM
SPSS® Version 24 (IBM, Portsmouth, UK). Univariate
analyses and Chi-square testing were first performed,
then binary logistic regression undertaken, calculating
adjusted odds ratios with generalised linear models, with
stepwise subtraction of variables, to investigate (un)-
adjusted epidemiological associations.
Results
Prevalence and distribution of intestinal and urogenital
schistosomiasis
The outline map, Fig. 2, is a summary of all information
obtained from urine CCA-dipsticks with the distribution
of intestinal schistosomiasis displayed. When ‘trace’ was
considered infected, mean prevalence was 82.5%. When
‘trace’ was considered not infected, this declined to
31.5%. Common across all school children were very
high levels of reported weekly water contact (> 75%), in-
clusive of bathing, swimming and drinking. The known
distribution of B. pfeifferi along the western shoreline,
alongside new reports on the eastern shoreline in De-
cember 2018 and May/June 2019, is shown. In locations
where B. pfeifferi was found, water parameters ranged:
pH 7.5–8.5, temperature 21.5–26.2 °C, conductivity 312–
458 μS and total dissolved salts 155–244 ppm; no
Table 1 Occurrence of ova-patent Schistosoma mansoni in stool and prevalence and intensity of S. haematobium infections by
school
School (sample size) Stool: Kato-Katz
(S. mansoni)
Urine: filtration
(S. haematobium)
Number
of stool
samples
collected
Prevalence
(%)
[95% CI]
Infection intensityα
(eggs per gram)
[% of positives]
Prevalence (%)
[95% CI]
Infection intensityβ
(eggs per 10 ml)
[% of positives]
Light Medium Heavy Light Heavy
TOTAL (n = 520) 335 * 20 [74.1] 4 [14.8] 3 [11.1] 24.0 [20.3–27.7] 80 [64.0] 45 [36.0]
All collected stools, irrespective of CCA status, were examined
Mchoka (n = 80) 73 1.4 [0.0–4.1] 1 [100.0] 0 [0.0] 0 [0.0] 18.8 [10.2–27.4] 11 [73.3] 4 [26.7]
Samama (n = 80) 77 5.2 [0.2–10.2] 4 [100.0] 0 [0.0] 0 [0.0] 56.3 [45.4–67.2] 30 [66.7] 15 [33.3]
MOET (n = 60) 56 3.6 [0.0–8.5] 2 [100.0] 0 [0.0] 0 [0.0] 8.3 [1.3–15.3] 3 [60.0] 2 [40.0]
Koche (n = 60) 59 15.3 [6.1–24.5] 3 [33.3] 3 [33.3] 3 [33.3] 1.7 [0.0–5.0] 1 [100.0] 0 [0.0]
Only selective stools from urine-CCA ‘positive’ children were examined
St Augustine II (n = 30) 15 * 3 [100.0] 0 [0.0] 0 [0.0] 43.3 [25.6–61.0] 8 [61.5] 5 [38.5]
Ndembo (n = 30) 15 * 6 [85.7] 1 [14.3] 0 [0.0] 60.0 [42.5–77.5] 7 [38.9] 11 [61.1]
Chikomwe (n = 30) 10 * 0 [−] 0 [−] 0 [−] 10.0 [0.0–20.7] 1 [33.3] 2 [66.7]
Chipeleka (n = 30) 3 * 0 [−] 0 [−] 0 [−] 26.7 [10.9–42.5] 4 [50.0] 4 [50.0]
Sungusya (n = 30) 7 * 0 [−] 0 [−] 0 [−] 16.7 [3.4–30.0] 4 [80.0] 1 [20.0]
St Martins (n = 30) 4 * 0 [−] 0 [−] 0 [−] 3.3 [0.0–9.7] 1 [100.0] 0 [0.0]
Makumba (n = 30) 6 * 1 [100.0] 0 [0.0] 0 [0.0] 6.7 [0.0–15.6] 2 [100.0] 0 [0.0]
Mtengeza (n = 30) 10 * 0 [−] 0 [−] 0 [−] 30.0 [13.6–46.4] 8 [88.9] 1 [11.1]
* unable to report prevalence due to selective stool sampling (8.1% of total stool collected was ova-patent; 15.7% of stool collected in selective sampling
was ova-patent)
α intensity by Kato-Katz: light: 1–99 epg; medium: 100–399 epg; heavy: ≥ 400 epg
β intensity by urine filtration: light: < 50 ova per 10 ml; heavy: ≥ 50 ova per 10 ml
- calculation not applicable
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collected snail (n = 52) was observed to shed S. mansoni
cercariae.
Ova-patent S. mansoni infections, including both
medium and heavy intensity infections, were observed
(see Table 1). Ova patent urogenital schistosomiasis was
detected in all schools, ranging from 1.7 to 60.0%, inclu-
sive of heavy intensity infections, except at Koche, St Mar-
tins and Makumba schools. Across our sample, 75 (14.4%)
children were considered ‘free’ from schistosomiasis; if
urine CCA-dipstick ‘trace’ was considered infected or
‘trace’ was considered not infected, then 109 (36.5%) or 56
(10.7%) children were judged co-infected with intestinal
and urogenital schistosomiasis, respectively.
Risk factors associated with schistosomiasis-associated
morbidity
Significant increases of schistosomiasis at Mchoka and
Samama were observed (see Fig. 3) even though MDA
treatment coverage (81.9%), as reported by interview,
was good. Relative risk of infection prevalence of S.
mansoni significantly increased at Samama (RR = 1.7,
95% CI: 1.4–2.2) and Mchoka (RR = 2.7, 95% CI: 1.7–
4.3) schools, indicative of substantive re-infection con-
current with increasing environmental transmission for
both types of schistosomiasis.
Analysis of risk factors associated with schistosomiasis-
associated morbidity (see Table 2) showed that ‘positive’
urine CCA-dipstick results and ova-patent S. mansoni
were significantly associated with FOB, alongside ova-
patent S. haematobium with microhaematuria. Neither
age nor gender were associated with these morbidity indi-
cators although a marginal protective effect of MDA, on
both FOB and microhaematuria, was observed.
Discussion
Our integrated surveillance approach was unified by three
linked cross-sectional surveys, see Fig. 1, and a conjoined
malacological inspection. Collectively this builds a more
thorough assessment of the changing epidemiology of in-
testinal and urogenital schistosomiasis on the Lake Malawi
shoreline (see Fig. 2 and Table 1). Of note, is that the
prevalence of both forms of schistosomiasis is increasing
(see Fig. 3), indicative perhaps that the force of infection
[13] for each parasite is rising, with intestinal schistosom-
iasis being of newest public health concern here.
Our study detected a mean prevalence of intestinal schis-
tosomiasis by ‘positive’ urine CCA-dipstick results of 31.5%
(95% CI: 27.5–35.5). Notably, significant increases in infec-
tion prevalence since May 2018 were observed at Samama
(RR = 1.7, 95% CI: 1.4–2.2) and Mchoka (RR = 2.7, 95% CI:
1.7–4.3) schools. The disease was also confirmed at MOET
(18.3%) and Koche (35.0%) schools with a broader geo-
graphical footprint apparent across the 8 rapid mapping
schools, with prevalence ranging from 10.0 to 56.7%, and
several extant populations of B. pfeifferi were confirmed on
the eastern and western lake shoreline. Concurrently mean
prevalence of urogenital schistosomiasis was 24.0% (95%
CI: 20.3–27.7) with 109 (36.5%) or 56 (10.7%) children co-
infected with intestinal schistosomiasis, as contingent upon
Fig. 3 The year-on-year increase of prevalence of urogenital (by urine filtration) and intestinal (by ‘trace/positive’ urine CCA-dipsticks)
schistosomiasis despite annual MDA across the two schools Mchoka and Samama as sampled in 2018 and 2019. Error bars indicate 95%
confidence intervals (CI). RR: relative risk
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interpretation of urine-CCA dipstick ‘trace’ as infection-
positive or negative, respectively.
The unexpected occurrence of intestinal schistosomia-
sis elsewhere in Malawi, alongside the more well-known
urogenital schistosomiasis, has been encountered before;
the surveys conducted by Poole et al. in Chikhwawa dur-
ing June 2012 noted that 24.9 and 9.1% of mothers and
their pre-school-aged children were positive by urine
CCA-dipsticks with ova-patent S. mansoni infections
confirmed [14]. While Biomphalaria was not detected in
their search for local snails [14], the occurrence of B.
pfeifferi, as shown here in Fig. 2, adds weight to their
postulate of intermittent transmission of S. mansoni in
Chikhwawa. They suggested that the occasional influx of
upstream populations of B. pfeifferi in the Shire River, as
being swept downstream during seasonal flooding, might
then colonize temporary pools in the Lower Shire River
flood plain, to spark sporadic transmission in Chikh-
wawa [14]. By contrast, an enduring presence of B. pfeif-
feri along Lake Malawi and Upper Shire River, gives rise
to more sustained opportunities in local transmission of
S. mansoni in Mangochi District.
In regard of this lake shoreline setting, we have shown
1) increases in the prevalence of intestinal schistosomia-
sis at Mchoka and Samama schools, 2) occurrence of
intestinal schistosomiasis at MOET and Koche schools
and 3) endemic intestinal schistosomiasis occurring
along a 80 km section of Lake Malawi and Shire River
shoreline, noting additional populations of B. pfeifferi on
the lake’s eastern shoreline (see Fig. 2). Of particular note
is the strong association of S. mansoni infection, as de-
tected by urine CCA-dipsticks, with FOB in 16.2% of ex-
amined children, see Table 2, indicative of overt intestinal
pathology [15]. Combined with the observations of ova-
patent infections of moderate- and heavy-intensities at
Koche and Ndembo, as well as, ova-patent infections at a
further five schools, this is pervasive evidence of more sus-
tained local transmission of intestinal schistosomiasis.
Whilst the debate on how to interpret ‘trace’ reactions
of urine-CCA dipsticks continues, a ‘positive’ reaction is
considered solid evidence of active intestinal schistosom-
iasis [12]. With no association detected between uro-
genital schistosomiasis and urine-CCA in our study, we
conclude that urine-CCA tests are highly specific for S.
mansoni detection, with ‘trace’ results indicating light
sub-clinical infections, with sub-patent egg outputs.
Therefore, 31.5% (95% CI: 27.5–35.5) of our sampled
children were suffering from intestinal schistosomiasis
but if a ‘trace’ reaction was considered diseased then a
total of 82.5% (95% CI: 79.2–85.8) were infected or, at
Table 2 Risk factors analyses for morbidity associated with urogenital and intestinal schistosomiasis upon detection of
microhematuria and faecal occult blood, respectively
Prevalence (%) [95% CI] Microhematuria Faecal occult blood (FOB)
31.5 [27.5–35.5] 16.2 [11.0–21.4]
Sample size n = 520 n = 191α
Unadjusted odds ratio
(95% CI) [P-value]
Adjusted odds ratio
(95% CI) [P-value]
Unadjusted odds ratio
(95% CI) [P-value]
Adjusted odds ratio
(95% CI) [P-value]
Urine-CCA testβ Negative 1 1 1 1
Positive 2.0 (1.4–3.0)
[< 0.01]
1.2 (0.6–2.6)
[0.61]
12.9 (4.3–38.7)
[< 0.01]
9.2 (3.0–28.6)
[< 0.01]
Ova-patent intestinal
schistosomiasis (Kato-Katz)
Negative 1 1 1 1
Positive 2.2 (1.0–4.7)
[0.06]
3.0 (1.0–8.6)
[0.04]
11.4 (3.9–33.3)
[< 0.01]
6.7 (2.0–22.6)
[< 0.01]
Ova-patent urogenital
schistosomiasis (urine filtration)
Negative 1 1 1 1
Positive 42.1 (23.2–76.5)
[< 0.01]
47.9 (22.6–101.5)
[< 0.01]
1.6 (0.7–3.8)
[0.25]
1.5 (0.5–4.9)
[0.49]
Praziquantel treatment in last 12
months
No 1 1 1 1
Yes 0.7 (0.5–1.1)
[0.16]
0.7 (0.3–1.8)
[0.45]
0.5 (0.2–1.3)
[0.16]
0.8 (0.3–2.3)
[0.65]
Gender Male 1 1 1 1
Female 1.0 (0.7–1.4)
[0.85]
0.9 (0.5–1.8)
[0.82]
1.1 (0.5–2.3)
[1.00]
1.0 (0.4–2.4)
[0.97]
Age (years) 6–10 1 1 1 1
11–15 0.9 (0.6–1.4)
[0.71]
1.2 (0.6–2.3)
[0.63]
1.1 (0.507–2.4)
[0.81]
0.9 (0.3–2.3)
[0.78]
α all total of 200 FOB tests were available being used at Samama, Mchoka and MOET schools;
β a trace result was considered here as not infected, only + ve urine CCA-dipstick scorings were considered infected; our conservative approach was based upon
correlates of urine CCA-dipsticks and duplicate Kato-Katz comparisons, with ova-patent prevalence of S. mansoni being ≥ 20%, see Bärenbold et al. [12]
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the very least, at-risk. Of particular note in this light is
intestinal schistosomiasis at Ndembo and St Augustine
II schools, see Fig. 2, where the prevalence of ‘positive’
urine-CCA dipsticks was > 50% and ova-patent S.
mansoni infections were encountered, being of light and
moderate infection intensities, Table 1; moreover, mod-
erate and heavy ova-patent S. mansoni infections were
detected at Koche school where the prevalence of
Fig. 4 a Composite satellite map, modified from GoogleEarth imagery, that illustrates the changing shoreline of the lake in 2005, 2012, 2013 and
2016. The featured area is the bay indicated by the black arrow labelled ‘A’ in Fig. 1. The green circle ‘M12’ denotes the sampling location where
numerus Biomphalaria have been found during all malacological inspections from November 2017 to December 2019. The changing shoreline is
most likely resultant from lowering lake levels, see b, as well as, upon influx of sediments from the seasonal river in the bottom part of this
image. b. Annual changes in the lake surface levels during 1992–2019 period (see https://ipad.fas.usda.gov/cropexplorer/global_reservoir/gr_
regional_chart.aspx?regionid = eafrica&reservoir_name = Malawi), as detected by remote altimetry, denoting two particularly low-level periods, in
1996–1998 and 2017–2019, which may help explain the changing shoreline shown in a as the lake recedes in depth. m MSL: meters above Mean
Sea Level
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‘positive’ urine-CCA dipsticks was 35.0%, with B. pfeifferi
found nearby.
Our rapid disease mapping surveillance across eight
schools, currently augments district-level information of
the national control programme, critically revising scien-
tific appraisals concerning the previous absence of intes-
tinal schistosomiasis [1], and better demonstrates the
newly defined endemicity of intestinal schistosomiasis
along the Mangochi District shoreline. When taken as a
whole, we judge that there is now sufficient evidence to
notify that an outbreak of intestinal schistosomiasis is
occurring. This has immediate bearing on the health of
the local populace and tourists who may visit here, as
well as, in health advice or diagnostic testing undertaken
in local or international medical clinics presently un-
aware of this new risk of intestinal schistosomiasis.
In terms of environmental surveillance, it is worthy to
note that the lake is undergoing ecological change, most
easily seen with lake level changes through time, see Fig. 4.
Its dynamic shoreline and lake level are manifest, perhaps
creating new habitats for B. pfeifferi to colonize and or were
facilitating collection of this snail in locations previously
too deep to be retrieved by hand. The dispersion of this
snail, a keystone species for S. mansoni, like in Senegal [9]
or in Ethiopia [7], is a critical epidemiological driver of in-
testinal schistosomiasis transmission.
Control of schistosomiasis needs a multisectoral ap-
proach and it is often debated how control tactics should
be changed [16] or better tailored to aquatic environments
[17]. To respond to this outbreak of intestinal schistosomia-
sis, we propose that current MDA efforts should be intensi-
fied, adopting biannual treatment cycles in schools, which
has been successfully implemented elsewhere [18], along-
side expanded access to praziquantel for all community
members with intestinal schistosomiasis, in need of regular
treatment throughout the year [19]. From recent surveys of
adult fishermen who have urogenital schistosomiasis, mak-
ing specific reference to male genital schistosomiasis, co-
infection with S. mansoni has been noted alongside re-
infections within a calendar year [20, 21]. To augment
MDA and community-access to praziquantel, it is import-
ant to strengthen health education and outreach with suit-
able water, sanitation and hygiene (WASH) interventions
[20, 22], better appropriate to this lakeshore setting, noting
that even focal application of molluscicides is inappropriate
[17], given this lake’s global importance in biodiversity.
A significant limitation of our study was the exclusion
of certain demographic groups in our survey. This in-
cluded pre-school-aged and out-of-school children, as well
as, more vulnerable adults [23]. However, with increased
future resourcing inspection of these groups is important
to better assess how they are each afflicted by this out-
break. To do so, we recommend a combination of both
rapid urine and faecal sampling methods with inspection
of a more extensive range of point-of-contact morbidity
markers to provide a better insight into individual disease
progression(s) [24]. Future use of 20m shuttle-run tests to
assess children’s aerobic capacity in relation to S. mansoni
infection could be insightful, as recently shown elsewhere
[25]. However, with coronavirus disease 2019 (COVID-19)
suspending annual MDA, we should expect and better
prepare for increasing severity of intestinal schistosomiasis
in following years.
Conclusions
Our three main study objectives were achieved: demon-
stration of increasing prevalence of intestinal and urogeni-
tal schistosomiasis at Samama and Mchoka schools, newly
confirmed intestinal schistosomiasis at previously non-
sampled schools near reported B. pfeifferi sites (MOET
and Koche schools), and detection of intestinal schisto-
somiasis at a further eight sampled schools along the
shoreline. Despite ongoing annual MDA of praziquantel
for urogenital schistosomiasis, we conclude that an out-
break of intestinal schistosomiasis is occurring in Mango-
chi District, Malawi. Increased vigilance for B. pfeifferi,
especially along the lake’s eastern shores and in down-
stream locations on the Shire River, is needed with add-
itional epidemiological inspections of adjacent schools and
communities to better gauge the full footprint of intestinal
schistosomiasis. Due to the COVID-19 pandemic, this
outbreak will continue to expand unchecked, but once
control activities can resume, we strongly recommend
stepping-up MDA treatment cycles, i.e. from annual to bi-
annual, increasing community access to praziquantel
treatment throughout the year, with renewed efforts to
mitigate environmental transmission with health educa-
tion and appropriate WASH interventions.
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